Descriptor English: | Ketanserin | ||||
Descriptor Spanish: |
Ketanserina
| ||||
Descriptor Portuguese: | Ketanserina | ||||
Descriptor French: | Kétansérine | ||||
Entry term(s): |
3-(2-(4-(4-Fluorobenzoyl)piperidinol)ethyl)-2,4(1H,3H)-quinazolinedione R 41,468 R 41468 R-41,468 R-41468 R41,468 R41468 |
||||
Tree number(s): |
D03.383.621.365 D03.633.100.786.830.333 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D007650 | ||||
Scope note: | A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients. |
||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Pharm Action: |
Antihypertensive Agents Platelet Aggregation Inhibitors Serotonin Antagonists |
||||
Registry Number: | 97F9DE4CT4 | ||||
CAS Type 1 Name: | 2,4(1H,3H)-Quinazolinedione, 3-(2-(4-(4-fluorobenzoyl)-1-piperidinyl)ethyl)- | ||||
Previous Indexing: |
Piperidines (1966-1986) |
||||
Public MeSH Note: | 87 |
||||
History Note: | 87 |
||||
DeCS ID: | 19223 | ||||
Unique ID: | D007650 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1987/01/01 | ||||
Date of Entry: | 1986/04/09 | ||||
Revision Date: | 2016/05/31 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Ketanserin
- Preferred
R-41,468
- Narrower
Concept UI |
M0011983 |
Scope note | A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients. |
Preferred term | Ketanserin |
Entry term(s) |
3-(2-(4-(4-Fluorobenzoyl)piperidinol)ethyl)-2,4(1H,3H)-quinazolinedione |
Concept UI |
M0353421 |
Preferred term | R-41,468 |
Entry term(s) |
R 41,468 R 41468 R-41468 R41,468 R41468 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey